Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP1132 | DOI: 10.1530/endoabs.81.EP1132

ECE2022 Eposter Presentations Thyroid (219 abstracts)

Long-term disease recurrence in the adipose tissue and striated muscle of a mimally invasive papillary thyroid carcinoma

Antonella Carbone 1 , Antonella Verrienti 2 , Domenico Savio Cito 3 , Marialuisa Sponziello 2 , Valeria Pecce 2 & Rocco Bruno 3


1Endocrine Unit, Area Medica, Pisticci, Italy; 2Department of Translational and Precision Medicine, Sapienza University, Rome, Italy; 1Endocrine Unit, Area Medica, Pisticci, Italy


Introduction: Differenziated thyroid carcinomas (DTC), particularly papillary thyroid carcinomas (PTCs), usually have an indolent behavior, howewer 10-20% of the patients develop recurrences, following surgery. There are several histological features associated with more frequent recurrences as the hystopathological variants of PTCs, the presence of vascular invasion or lymph node metastases and the presence of extrathyroidal extension (ETE). Case history: a 56yrs old male patient prevously treated for PTC, with excellent response to the first treatment, presented twelve years after a gradual increase of thyroglobulin (Tg) (from 0.3 to 0.76 ng/ml in 6 months) and a neck lump in the left cervical region at ultrasound imaging. Fine needle aspiration cytology of the mass and Tg measurement in the wash out liquid of the needle was 472 mg/l. Cytology revealed polymorphous epithelial cells with atypical nuclei suggesting metastasis of PTC. Surgery was then performed and pathology showed a massive metastasis in the local adipose tissue and striated muscles of the neck. Genetic analysis of the primary tumor and metastatic tissue revelead a BRAF p. V600E in both primary tumor and in metastatic tissue (37% and 48% respectively). Conclusions: Our patient’s history suggests the need of a continuous and prolonged follow-up in patients with multiple features that increase the recurrence risk (minimal ETE, size >2 cm, BRAF V600E mutation as in our case).

References: 1 B.R Haugen, E.K. Alexander, K.C. Bible et al. (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differenziated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26,1-133. 2 M. Shteinshnaider, L.M. Kalmovic, S. Koren et al. (2018) Reassessment of differentiated thyroid cancer patients using the eighth TNM/AJCC classification system: a comparative study. Thyroid 28(2), 201-209. 3 D.L.S. Danilovic, L.A. Castroneves, C.K. Suemoto et al. (2020) Is there a difference between minimal and gross extension into the strap muscles for the risk of recurrence in papillary thyroid carcinomas. Thyroid 30(7), 1008-1016. 4 T. Diker- Cohen, D. Hirsch, I. Shimon et al. (2018) Impact of minimal extrathyroid extension in differentiated thyroid cancer : sistematic review and meta-analysis. J Clin. Endocrinol. Metab. 103 2100-2106. 5 T. P. de Castro, R. c. C. Penha et al. (2020) Molecular predictors for advanced papillary thyroid carcinoma recurrence. Front. Endocrinol.10, 839.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.